{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:01:22Z","timestamp":1790910082165,"version":"4.1.0"},"reference-count":40,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,24]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>We investigated the outcomes of 179 pediatric patients with severe aplastic anemia (SAA) who received up-front hematopoietic stem cell transplantation (HSCT; n = 87) or received HSCT after failure of immunosuppressive therapy (IST; n = 92). With a median follow-up of 4.0 years (range, 0.2-10.7) after HSCT, 161 patients were alive at last follow-up. The cumulative incidence of graft failure, grade 2 to 4 acute and chronic graft-versus-host disease (GVHD) was 10%, 18%, and 8%, respectively. Five-year overall survival (OS) and GVHD-free, relapse\/rejection-free survival (GRFS) were 89% and 79%, respectively. Patients who received up-front HSCT from a matched sibling donor (MSD) or \u22659\/10 HLA-matched unrelated donor (MUD) both achieved an OS of 95%. OS was superior in patients who received up-front HSCT than those who received HSCT after failure of IST (up-front, 95% [95% CI, 89-100] vs after IST failure, 83% [95% CI,75-91]; P &amp;lt; .01). However, OS in the HSCT group after IST failure improved over time, resulting in comparable OS between up-front HSCT and HSCT after IST failure from 2015 (97% vs 89%; P = .09). Moreover, there was no difference in GRFS of MUD-HSCT comparing patients who received a transplant up front or after IST failure (up-front, 77% vs after IST failure, 76%; P value not significant). Our data highlight the good transplant outcomes of a consecutive pediatric SAA cohort. Although up-front HSCT from a readily available MUD is a viable option if an MSD is not available, HSCT after IST failure from a well-matched unrelated donor also yields favorable outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018285","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T21:59:51Z","timestamp":1768946391000},"page":"1992-2005","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Comparable outcomes of HSCT up-front and after failure of IST in pediatric aplastic anemia in recent years"],"prefix":"10.1182","volume":"10","author":[{"given":"Felicia","family":"Andresen","sequence":"first","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1593-9507","authenticated-orcid":false,"given":"Ayami","family":"Yoshimi","sequence":"additional","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bader","sequence":"additional","affiliation":[{"name":"2Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0192-3080","authenticated-orcid":false,"given":"Marc","family":"Bierings","sequence":"additional","affiliation":[{"name":"3Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Bod\u2019ov\u00e1","sequence":"additional","affiliation":[{"name":"4Bone Marrow Transplantation Unit, Department of Pediatric Hematology and Oncology, National Institute of Children's Diseases, Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Bordon","sequence":"additional","affiliation":[{"name":"5Department of Pediatric Hematology-Oncology, Ghent University Hospital Gent, Gent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5848-4501","authenticated-orcid":false,"given":"Jochen","family":"Buechner","sequence":"additional","affiliation":[{"name":"6Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1151-829X","authenticated-orcid":false,"given":"Birgit","family":"Burkhardt","sequence":"additional","affiliation":[{"name":"7Department of Pediatric Hematology, Oncology and Bone Marrow Transplantation, University Hospital Muenster, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dworzak","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics and Adolescent Medicine, St. Anna Children\u2019s Hospital, Medical University of Vienna, Vienna, Austria"},{"name":"9St. Anna Children\u2019s Cancer Research Institute, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7261-1447","authenticated-orcid":false,"given":"Miriam","family":"Erlacher","sequence":"additional","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"},{"name":"10Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4328-9612","authenticated-orcid":false,"given":"Kriszti\u00e1n","family":"K\u00e1llay","sequence":"additional","affiliation":[{"name":"11Department of Pediatric Hematology and Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Labarque","sequence":"additional","affiliation":[{"name":"12Department of Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7976-3654","authenticated-orcid":false,"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[{"name":"13Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Ges\u00f9, Catholic University of the Sacred Heart, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Malone","sequence":"additional","affiliation":[{"name":"14Paediatric Haematology, Children's Health Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Masmas","sequence":"additional","affiliation":[{"name":"15Pediatric Hematopoietic Stem Cell Transplantation and Immunodeficiency, The Child and Adolescent Department, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-6632","authenticated-orcid":false,"given":"Ingo","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"16Division for Pediatric Stem Cell Transplantation and Immunology, Clinic for Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0281-4732","authenticated-orcid":false,"given":"Peter","family":"N\u00f6llke","sequence":"additional","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4745-8572","authenticated-orcid":false,"given":"Markus","family":"Schmugge","sequence":"additional","affiliation":[{"name":"17Department of Hematology, Oncology and Stem Cell Transplantation, University Children's Hospital, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4402-582X","authenticated-orcid":false,"given":"Katarzyna","family":"Pawelec","sequence":"additional","affiliation":[{"name":"18Department of Pediatric Transplantology, Oncology and Hematology, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7895-2886","authenticated-orcid":false,"given":"Petr","family":"Sedlacek","sequence":"additional","affiliation":[{"name":"19Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6852-1860","authenticated-orcid":false,"given":"Julian","family":"Sevilla","sequence":"additional","affiliation":[{"name":"20Hematology and Hemotherapy Unit, Hospital Infantil Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Smith","sequence":"additional","affiliation":[{"name":"14Paediatric Haematology, Children's Health Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6818-7743","authenticated-orcid":false,"given":"Jan","family":"Stary","sequence":"additional","affiliation":[{"name":"19Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3856-7937","authenticated-orcid":false,"given":"Charlotte","family":"Niemeyer","sequence":"additional","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6086-130X","authenticated-orcid":false,"given":"Brigitte","family":"Strahm","sequence":"additional","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"17","key":"2026032014063699600_bib1","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"2026032014063699600_bib2","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3324\/haematol.2014.109355","article-title":"First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy","volume":"99","author":"Yoshida","year":"2014","journal-title":"Haematologica"},{"issue":"4","key":"2026032014063699600_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/bjh.13297","article-title":"Outcome of aplastic anaemia in children. A study by the Severe Aplastic Anaemia and Paediatric Disease Working Parties of the European Group Blood and Bone Marrow Transplant","volume":"169","author":"Dufour","year":"2015","journal-title":"Br J Haematol"},{"issue":"6","key":"2026032014063699600_bib4","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jpeds.2008.06.004","article-title":"Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine","volume":"153","author":"Scheinberg","year":"2008","journal-title":"J Pediatr"},{"issue":"10","key":"2026032014063699600_bib5","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3324\/haematol.2018.206540","article-title":"Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study","volume":"104","author":"Rogers","year":"2019","journal-title":"Haematologica"},{"issue":"5","key":"2026032014063699600_bib6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1182\/blood-2012-10-461509","article-title":"Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children","volume":"121","author":"Yoshimi","year":"2013","journal-title":"Blood"},{"issue":"7","key":"2026032014063699600_bib7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/ajh.27334","article-title":"Comparison of outcomes of immunosuppressive therapy with rabbit versus horse antithymocyte globulin and cyclosporine A in children with acquired severe aplastic anemia","volume":"99","author":"Yoshimi","year":"2024","journal-title":"Am J Hematol"},{"issue":"1","key":"2026032014063699600_bib8","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/ajh.26354","article-title":"Upfront unrelated donor hematopoietic stem cell transplantation in patients with idiopathic aplastic anemia: a retrospective study of the Severe Aplastic Anemia Working Party of European Bone Marrow Transplantation","volume":"97","author":"Petit","year":"2022","journal-title":"Am J Hematol"},{"issue":"10","key":"2026032014063699600_bib9","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/bmt.2009.378","article-title":"Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia","volume":"45","author":"Yagasaki","year":"2010","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"2026032014063699600_bib10","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3324\/haematol.2014.115345","article-title":"Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis","volume":"100","author":"Bacigalupo","year":"2015","journal-title":"Haematologica"},{"issue":"4","key":"2026032014063699600_bib11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bjh.13614","article-title":"Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT","volume":"171","author":"Dufour","year":"2015","journal-title":"Br J Haematol"},{"issue":"25","key":"2026032014063699600_bib12","first-page":"3031","article-title":"Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia","volume":"141","author":"DeZern","year":"2023","journal-title":"Blood"},{"issue":"1","key":"2026032014063699600_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2559.2011.04156.x","article-title":"Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria","volume":"61","author":"Baumann","year":"2012","journal-title":"Histopathology"},{"issue":"8580","key":"2026032014063699600_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(88)90388-1","article-title":"Criteria for severe aplastic anaemia","volume":"1","author":"Camitta","year":"1988","journal-title":"Lancet"},{"issue":"1","key":"2026032014063699600_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000353118","article-title":"Cytogenetic nomenclature: changes in the ISCN 2013 compared to the 2009 edition","volume":"141","author":"Simons","year":"2013","journal-title":"Cytogenet Genome Res"},{"issue":"8","key":"2026032014063699600_bib16","first-page":"642","article-title":"Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the American Society for Transplantation and Cellular Therapy","volume":"27","author":"Kharfan-Dabaja","year":"2021","journal-title":"Transpl Cell Ther"},{"issue":"11","key":"2026032014063699600_bib17","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","article-title":"EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"2026032014063699600_bib18","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/s41375-022-01636-8","article-title":"Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia","volume":"36","author":"Groarke","year":"2022","journal-title":"Leukemia"},{"issue":"5","key":"2026032014063699600_bib19","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJMoa1103975","article-title":"Horse versus rabbit antithymocyte globulin in acquired aplastic anemia","volume":"365","author":"Scheinberg","year":"2011","journal-title":"N Engl J Med"},{"issue":"23","key":"2026032014063699600_bib20","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1182\/blood-2012-02-407684","article-title":"Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party","volume":"119","author":"Marsh","year":"2012","journal-title":"Blood"},{"issue":"9","key":"2026032014063699600_bib21","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2014.106542","article-title":"In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia","volume":"99","author":"Feng","year":"2014","journal-title":"Haematologica"},{"issue":"8","key":"2026032014063699600_bib22","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood-2006-09-045625","article-title":"Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia","volume":"109","author":"Scheinberg","year":"2007","journal-title":"Blood"},{"issue":"4","key":"2026032014063699600_bib23","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2007-03-081596","article-title":"Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia","volume":"110","author":"Schrezenmeier","year":"2007","journal-title":"Blood"},{"issue":"7","key":"2026032014063699600_bib24","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bbmt.2010.10.029","article-title":"Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia","volume":"17","author":"Chu","year":"2011","journal-title":"Biol Blood Marrow Transpl"},{"issue":"8","key":"2026032014063699600_bib25","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3324\/haematol.2011.054841","article-title":"Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups","volume":"97","author":"Bacigalupo","year":"2012","journal-title":"Haematologica"},{"issue":"4","key":"2026032014063699600_bib26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu364","article-title":"Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European Group for Blood and Marrow Transplantation","volume":"59","author":"Ljungman","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"20","key":"2026032014063699600_bib27","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis","volume":"127","author":"Teira","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2026032014063699600_bib28","first-page":"82.e1-82.e8","article-title":"Negative impact of cytomegalovirus reactivation on survival in adult patients with aplastic anemia after an allogeneic hematopoietic stem cell transplantation: a report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell Transplantation","volume":"27","author":"Takenaka","year":"2021","journal-title":"Transpl Cell Ther"},{"issue":"9","key":"2026032014063699600_bib29","first-page":"2305","article-title":"Graft-versus-host disease and relapse\/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT","volume":"108","author":"Devillier","year":"2023","journal-title":"Haematologica"},{"issue":"7","key":"2026032014063699600_bib30","doi-asserted-by":"crossref","first-page":"e13552","DOI":"10.1111\/petr.13552","article-title":"Allogeneic bone marrow transplants for pediatric severe aplastic anemia: real-world data comparing matched related and unrelated donors in a developing country. Retrospective study on behalf of the Pediatric Hematopoietic Stem Cell Transplant Working Group of the Brazilian Bone Marrow Transplantation Society (SBTMO) and the Brazil-Seattle Consortium (Gedeco)","volume":"23","author":"Darrigo","year":"2019","journal-title":"Pediatr Transpl"},{"issue":"10","key":"2026032014063699600_bib31","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/s41409-020-0897-2","article-title":"Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation (SAAWP of EBMT)","volume":"55","author":"ElGohary","year":"2020","journal-title":"Bone Marrow Transpl"},{"issue":"10","key":"2026032014063699600_bib32","doi-asserted-by":"crossref","first-page":"e28444","DOI":"10.1002\/pbc.28444","article-title":"A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: a joint pilot trial of the North American Pediatric Aplastic Anemia Consortium and the Pediatric Transplantation and Cellular Therapy Consortium","volume":"67","author":"Pulsipher","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2026032014063699600_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/bloodadvances.2021005628","article-title":"TCRalphabeta\/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders","volume":"6","author":"Merli","year":"2022","journal-title":"Blood Adv"},{"issue":"2","key":"2026032014063699600_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br J Haematol"},{"issue":"8","key":"2026032014063699600_bib35","doi-asserted-by":"crossref","first-page":"e31070","DOI":"10.1002\/pbc.31070","article-title":"Treatment of newly diagnosed severe aplastic anemia in children: evidence-based recommendations","volume":"71","author":"Shimano","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2026032014063699600_bib36","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood.V84.3.941.941","article-title":"Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia","volume":"84","author":"Storb","year":"1994","journal-title":"Blood"},{"issue":"1","key":"2026032014063699600_bib37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/10428194.2010.524328","article-title":"Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia","volume":"52","author":"Anderlini","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"2026032014063699600_bib38","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1182\/blood-2010-12-327536","article-title":"Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia","volume":"118","author":"Marsh","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2026032014063699600_bib39","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1016\/S2352-3026(15)00147-7","article-title":"Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study","volume":"2","author":"Anderlini","year":"2015","journal-title":"Lancet Haematol"},{"issue":"20","key":"2026032014063699600_bib40","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1182\/bloodadvances.2019000722","article-title":"Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia","volume":"3","author":"Bejanyan","year":"2019","journal-title":"Blood Adv"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/6\/1992\/2508489\/blooda_adv-2025-018285-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/6\/1992\/2508489\/blooda_adv-2025-018285-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T18:06:49Z","timestamp":1774030009000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/6\/1992\/566138\/Comparable-outcomes-of-HSCT-up-front-and-after"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,3,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018285","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,24]]},"published":{"date-parts":[[2026,3,13]]}}}